List of Treatments for Lung Cancer

Erlotinib

Overview
Erlotinib is approved by the U.S. Food and Drug Administration (FDA) for the treatment of metastatic non-small cell lung cancer (NSCLC). It is specifically used in those whose tumors have EGFR exon 19 deletions…

Alecensa (Alectinib)

Overview
Alecensa is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) as detected by an… read more

Alimta (Pemetrexed)

Overview
Alimta is approved by the U.S. Food and Drug Administration (FDA) to treat certain types of non-squamous non-small cell lung cancer (NSCLC). Alimta can be used in different ways depending on the stage and type of…

Alunbrig (Brigatinib)

Overview
Alunbrig is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with ALK-positive metastatic non-small cell lung cancer (NSCLC), as detected by an FDA-approved test. Alunbrig is…

Augtyro (Repotrectinib)

Overview
Augtyro is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with locally advanced or metastatic ROS1-positive non-small cell lung cancer. Augtyro is also referred to… read more

Avastin (Bevacizumab)

Overview
Avastin is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat metastatic, non-squamous, non-small cell lung cancer, as well as other types of cancer. Avastin is usually… read more

Braftovi (Encorafenib)

Overview
Braftovi is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with metastatic non-small cell lung cancer (NSCLC) with a BRAF V600E mutation. It’s indicated to be used in…

Catheter Placement

Overview
Catheter placement is a procedure used to remove excess fluid surrounding the lungs. In some cases of lung cancer, fluid builds up in the area of the chest outside the lungs and underneath the chest wall. This… read more

Chemotherapy

Overview
Chemotherapy is the treatment of cancer with drugs. Chemotherapy drugs may be given intravenously or orally after surgery (adjuvant chemotherapy) or before surgery (neoadjuvant chemotherapy). The goal of… read more

Cyramza (Ramucirumab)

Overview
Cyramza is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat metastatic non-small cell lung cancer (NSCLC). Cyramza is often prescribed with erlotinib or docetaxel, two… read more

Enhertu (Fam-Trastuzumab Deruxtecan-Nxki)

Overview
Enhertu is approved by the U.S. Food and Drug Administration (FDA) for treating adults with unresectable or metastatic non-small cell lung cancer (NSCLC) whose tumors have activating HER2 (ERBB2) mutations and…

Gavreto (Pralsetinib)

Overview
Gavreto is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with metastatic, rearranged-during-transfection (RET) fusion-positive, non-small cell lung cancer as… read more

Gemzar (Gemcitabine)

Overview
Gemzar is approved by the U.S. Food and Drug Administration (FDA) for use in combination with the chemotherapy drug cisplatin for the treatment of non-small cell lung cancer (NSCLC). Gemzar is also known by its…

Gilotrif (Afatinib)

Overview
Gilotrif is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat metastatic non-small cell lung cancer (NSCLC) with nonresistant epidermal growth factor receptor mutations as… read more

Imdelltra (Tarlatamab-Dlle)

Overview
Imdelltra is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with extensive stage small cell lung cancer (SCLC) — cancer that has spread — whose disease has progressed…

Imfinzi (Durvalumab)

Overview
Imfinzi is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating extensive small-cell lung cancer and late-stage (locally advanced or metastatic) non-small cell lung… read more

Imjudo (Tremelimumab-Actl)

Overview
Imjudo is approved by the U.S. Food and Drug Administration (FDA) in combination with durvalumab and platinum-based chemotherapy for the treatment of adults with metastatic non-small cell lung cancer (NSCLC)…

Iressa (Gefitinib)

Overview
Iressa is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat metastatic, non-small cell lung cancer whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions… read more

Keytruda (Pembrolizumab)

Overview
Keytruda is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat metastatic small cell lung cancer and various non-small cell lung cancers. Keytruda is also referred to by its… read more

Krazati (Adagrasib)

Overview
Krazati is a brand name for the drug Adagrasib, which is approved by the U.S. Food and Drug Administration (FDA) for the treatment of non-small cell lung cancer (NSCLC) in adults. Specifically, it is used as a…

Laser Therapy

Overview
Laser therapy for lung cancer involves the use of a strong, focused light to destroy a small tumor in the lining of an airway or to decrease the size of a tumor that is blocking an airway. It is typically used… read more

Libtayo (Cemiplimab-Rwlc)

Overview
Libtayo is approved by the U.S. Food and Drug Administration (FDA) for the treatment of non-small cell lung cancer (NSCLC) in adults. A person must have no EGFR, ALK, or ROS1 genetic mutations, and their cancer…

Lobectomy

Overview
Lobectomy surgery, or removing a lobe from a lung, is a treatment for advanced non-small cell lung cancer. The left lung has two lobes and the right has three.

What does it involve?
The procedure is… read more

Lorbrena (Lorlatinib)

Overview
Lorbrena is approved by the U.S. Food and Drug Administration (FDA) for treating adults with metastatic non-small cell lung cancer (NSCLC) whose tumors are ALK-positive. The FDA requires an approved test to…

Lumakras (Sotorasib)

Overview
Lumakras is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC) who have received at least…

Mekinist (Trametinib)

Overview
Mekinist is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat metastatic non-small cell lung cancer with a mutation of the BRAF V600E gene as detected by an FDA-approved test.… read more

Mektovi (Binemetinib)

Overview
Mektovi is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with metastatic non-small cell lung cancer (NSCLC) with a BRAF V600E mutation. It’s indicated to be used in…

Opdivo (Nivolumab)

Overview
Opdivo is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat metastatic non-small cell lung cancer. Opdivo is often prescribed with ipilimumab (Yervoy). Opdivo is also known by… read more

Optune Lua

Overview
Optune Lua is approved by the U.S. Food and Drug Administration (FDA) for the treatment of metastatic non-small cell lung cancer (NSCLC) in adults who have progressed on or after a platinum-based chemotherapy…

Pericardial Window

Overview
Creating a pericardial window is a procedure that drains excess fluid from the chest by removing a portion of the pericardium (the sac that surrounds the heart).

In certain cases of lung cancer, fluid can… read more

Pericardiocentesis

Overview
Pericardiocentesis is a procedure to remove excess fluid near the heart. In certain cases of lung cancer, fluid can accumulate in the upper chest cavity near the heart. The fluid can then penetrate the… read more

Photodynamic Therapy

Overview
Photodynamic therapy uses a combination of medication and light to kill cancer cells. It is also known as photoradiation therapy, phototherapy, or photochemotherapy. It’s used as a treatment for early-stage… read more

Pleurodesis

Overview
Pleurodesis is a procedure that attaches the lungs to the chest wall. In certain cases of lung cancer, fluid builds up in the pleural space (the area between the lungs and the chest wall). This is known as… read more

Pneumonectomy

Overview
Pneumonectomy, a surgery to remove an entire lung, is used to treat advanced lung cancer. If cancer has spread through most of a lung, is present in the middle of a lung, or involves an artery or multiple… read more

Portrazza (Necitumumab)

Overview
Portrazza is approved by the U.S. Food and Drug Administration (FDA) for use in combination with the chemotherapy drugs gemcitabine and cisplatin for the first-line treatment of metastatic squamous non-small cell…

Radiation Therapy

Overview
Radiation therapy kills cancer cells using high-energy rays or particles. It may be used as the main treatment for non-small cell lung cancer (NSCLC) when the cancer can’t be removed surgically. It may be used… read more

Radiofrequency Ablation

Overview
Radiofrequency ablation is a treatment approved by the U.S. Food and Drug Administration (FDA) for people with non-small cell lung cancer when surgery is not an option. It is typically used to treat small… read more

Retevmo (Selpercatinib)

Overview
Retevmo is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with metastatic, rearranged-during-transfection (RET) fusion-positive, non-small cell lung cancer. Retevmo… read more

Robotically Assisted Thoracic Surgery (RATS)

Overview
Robotically assisted thoracic surgery (RATS) is a procedure approved by the U.S. Food and Drug Administration (FDA) for certain people with lung cancer. It is used to facilitate several other different… read more

Rozlytrek (Entrectinib)

Overview
Rozlytrek is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with non-small cell lung cancer (NSCLC) that has spread to other parts of the body and is caused by an… read more

Rybrevant (Amivantamab-Vmjw)

Overview
Rybrevant is approved by the U.S. Food and Drug Administration (FDA) for the treatment of lung cancer. It is specifically indicated for adults with locally advanced or metastatic non-small cell lung cancer…

Segmentectomy

Overview
Segmentectomy, also called wedge resection, is a surgical procedure used to treat non-small cell lung cancer. It is typically performed when lung cancer is in its earliest stages or when a person’s lung… read more

Sleeve Resection

Overview
Sleeve resection surgery is a procedure used to treat certain people with non-small cell lung cancer. Sleeve resection is performed by opening the chest and removing a lobe from a lung, along with some nearby… read more

Stent Placement

Overview
Stent placement is a procedure in which a stent — a flexible mesh tube — is placed in an airway to keep it from becoming blocked. If a lung cancer grows into an airway and affects breathing, a stent can help… read more

Tabrecta (Capmatinib)

Overview
Tabrecta is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with metastatic, non-small cell lung cancer whose tumors have a mutation known as mesenchymal-epithelial… read more

Tafinlar (Dabrafenib)

Overview
Tafinlar is a brand name for the drug Dabrafenib, which is approved by the U.S. Food and Drug Administration (FDA) for the treatment of individuals with metastatic non-small cell lung cancer (NSCLC) with the BRAF…

Tagrisso (Osimertinib)

Overview
Tagrisso is approved by the U.S. Food and Drug Administration (FDA) for several indications related to non-small cell lung cancer (NSCLC). It is used as an adjuvant therapy (additional treatment following…

Tarceva (Erlotinib)

The Tarceva brand name has been discontinued in the U.S. Generic alternatives may be available.

Overview

Tarceva is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat locally advanced or…

Taxotere (Docetaxel)

Overview
Taxotere is approved by the U.S. Food and Drug Administration (FDA) for use as a treatment for non-small cell lung cancer (NSCLC), along with other types of cancer. Taxotere is typically prescribed when prior…

Tecentriq (Atezolizumab)

Overview
Tecentriq is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with small cell or non-small cell lung cancer by itself or as an adjuvant therapy (in combination with… read more

Tecentriq Hybreza (Atezolizumab and Hyaluronidase-Tqjs)

Overview
Tecentriq Hybreza, a combination of atezolizumab and hyaluronidase, is approved by the U.S. Food and Drug Administration (FDA) for treating various forms of lung cancer, including non-small cell lung cancer…

Tepmetko (Tepotinib)

Overview
Tepmetko is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with metastatic non-small cell lung cancer (NSCLC) who have MET exon 14 skipping alterations, as confirmed by a…

Thoracentesis

Overview
Thoracentesis is a procedure used to remove excess fluid from the chest. In some cases of lung cancer, fluid builds up in the pleural space (the area between the lungs and the chest wall). This condition is… read more

Video-Assisted Thoracic Surgery (VATS)

Overview
Video-assisted thoracic surgery (VATS) is a procedure approved by the U.S. Food and Drug Administration (FDA) for certain people with lung cancer. It is typically used to biopsy a lung or another area in the… read more

Vitrakvi (Larotrectinib)

Overview
Vitrakvi is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat solid tumors that have a neurotrophic receptor tyrosine kinase (NTRK) gene fusion without a known resistance… read more

Vizimpro (Dacomitinib)

Overview
Vizimpro is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat metastatic non-small cell lung cancer with epidermal growth factor receptor (EGFR) exon 19 deletion or exon 21… read more

Xalkori (Crizotinib)

Overview
Xalkori is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat metastatic non-small cell lung cancer (NSCLC) with tumors that are positive for anaplastic lymphoma kinase (ALK)… read more

Yervoy (Ipilimumab)

Overview
Yervoy is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat metastatic non-small cell lung cancer with tumors that express the protein PD-L1. Yervoy is prescribed in… read more

Zelboraf (Vemurafenib)

Overview
Zelboraf is approved by the U.S. Food and Drug Administration (FDA) for the treatment of metastatic or unresectable melanoma with a BRAF V600E mutation and for Erdheim-Chester Disease with a BRAF V600 mutation…

Zykadia (Ceritinib)

Overview
Zykadia is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with metastatic non-small cell lung cancer (NSCLC) whose tumors are positive for anaplastic lymphoma kinase… read more